Tirzepatide

The clinical trials for tirzepatide included both men and women, and the headline results, average weight loss of around 20 percent of body weight…

Tirzepatide shows promise in reducing alcohol cravings through GLP-1 receptor mechanisms, with emerging clinical evidence supporting AUD treatment

Tirzepatide shows promise for smoking cessation through dopamine pathway modulation and craving reduction mechanisms beyond weight loss alone.

Tirzepatide does not directly cause gambling addiction, but GLP-1 agonists may alter dopamine pathways in susceptible individuals — here’s what the

Tirzepatide doesn’t directly cause social anxiety, but weight loss transitions and metabolic shifts can amplify existing concerns. What patients need to

Tirzepatide may trigger compulsive shopping in some patients through dopamine pathway changes. Research shows GLP-1 medications can alter reward-seeking

Tirzepatide shows potential neuroprotective effects in Parkinson’s research. Understand the mechanisms, current evidence, and what patients should know in

Tirzepatide shows promising neuroprotective effects in Alzheimer’s research through GLP-1 receptor pathways that reduce neuroinflammation and enhance

Tirzepatide poses no addiction risk but requires careful medical oversight during recovery. GLP-1 medications can support metabolic health when substance